BIO-TECHNE Corp Quarterly Deferred Income Tax Liabilities, Net in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
BIO-TECHNE Corp quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q2 2019 to Q3 2024.
  • BIO-TECHNE Corp Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2024 was $50M, a 39.8% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $50M -$33.1M -39.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $55.9M -$33.1M -37.2% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $63.7M -$30.9M -32.7% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $71.6M -$39.8M -35.7% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $83.1M -$29.8M -26.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $89M -$10M -10.1% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $94.6M -$4.69M -4.73% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $111M +$9.96M +9.82% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $113M +$14.1M +14.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $99M +$5.87M +6.3% Jun 30, 2022 10-K 2023-08-23
Q1 2022 $99.3M +$900K +0.92% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $101M -$3.92M -3.72% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $98.8M -$2.56M -2.53% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $93.1M -$7.97M -7.88% Jun 30, 2021 10-K 2022-08-24
Q1 2021 $98.4M +$2.22M +2.31% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $105M Dec 31, 2020 10-Q 2021-02-08
Q3 2020 $101M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $101M +$11.3M +12.6% Jun 30, 2020 10-K 2021-08-25
Q1 2020 $96.2M Mar 31, 2020 10-Q 2020-05-11
Q2 2019 $89.8M Jun 30, 2019 10-K 2020-08-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.